trending Market Intelligence /marketintelligence/en/news-insights/trending/96bqj2bfjh_rgoxdcxu4yq2 content esgSubNav
In This List

Biostage adds hospital executive to board

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Biostage adds hospital executive to board

Holliston, Mass.-based Biostage Inc. named James Shmerling as a board member.

Shmerling is the president and CEO of Connecticut Children's Medical Center.

"Biostage is collaborating with Connecticut Children's Medical Center to translate our Cellframe technology from pre-clinical studies to clinical trials to address pediatric esophageal atresia, and the addition of Jim to our board supports the vision of this collaboration," Biostage CEO James McGorry said in a statement.

Biostage is a biotechnology company that engages in developing bioengineered organ implants.